Checkpoint Immunotherapy Approved for Patients with Stomach, Gastroesophageal, and Liver Cancer September 25, 2017December 14, 2022 Arthur N. Brodsky, PhD
FDA Approves Pembrolizumab Immunotherapy for Advanced Liver Cancer November 9, 2018December 14, 2022 Arthur N. Brodsky, PhD
How Immunotherapy Is Making an Impact in Liver Cancer December 21, 2018December 14, 2022 Arthur N. Brodsky, PhD